Cost comparison of post-remission strategies in younger and older AML patients in France

Blood Cancer J. 2023 Jun 28;13(1):100. doi: 10.1038/s41408-023-00874-y.
No abstract available

Publication types

  • Letter

MeSH terms

  • Costs and Cost Analysis
  • France / epidemiology
  • Humans
  • Leukemia, Myeloid, Acute* / therapy